The firm expects to save more than $35 million in annualized costs through the restructuring. CEO Anne Wojcicki told ...

The genetic testing company 23andMe hasn't been doing so hot lately, watching its share price plummet more than 70% this year ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but necessary ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

This has raised concerns about what will happen to the troves of genetic data it has in its possession. The company’s chief ...

Despite a revenue decline, 23andMe Holding Co (ME) focuses on cost-saving measures and recurring revenue growth to enhance financial stability.

Anne Wojcicki; Chairman of the Board, President, Chief Executive Officer, Co-Founder; 23andMe Holding Co. Joseph Selsavage; Interim Chief Financial Officer, Chief Accounting Officer; 23andMe Holding ...

CEO Anne Wojcicki, who holds roughly half of the voting power, is attempting to take the company private. In September, seven ...

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company announced that it has decided on a restructuring ...

"We are taking these difficult but necessary actions to restructure 23andMe and focus on the long-term success of our core ...